Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: A controlled trial

Journal of Clinical Psychopharmacology

Volumn 33, Issue 2, 2013, Pages 193-198

  Walter, Marc ^a   Gerber, Hana ^a   Kuhl, Hans Christian ^a   Schmid, Otto ^a   Joechle, Wolfgang ^b   Lanz, Christian ^c   Brenneisen, Rudolf ^c   Schächinger, Hartmut ^d   Riecher Rössler, Anita ^a   Wiesbeck, Gerhard A ^a   Borgwardt, Stefan J ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF TRIER   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

addiction; cortisol; diacetylmorphine (DAM); heroin dependence; heroin assisted treatment (HAT); hypothalamic pituitary adrenal (HPA) axis

Indexed keywords

CORTICOTROPIN; DIAMORPHINE; HYDROCORTISONE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HEROIN DEPENDENCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WITHDRAWAL SYNDROME;

ADRENOCORTICOTROPIC HORMONE; ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84874935180     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31828393cb     Document Type: Article

References (39)

1. Leshner AI. Addiction is a brain disease, and it matters. Science. 1997;278:45-47. (Pubitemid 27446268)
2. Kiefer F, Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict Biol. 2004;9:205-212. (Pubitemid 39491045)
3. Walter M, Gerhard U, Gerlach M, et al. Cortisol concentrations, stress-coping styles after withdrawal, and long-term abstinence in alcohol dependence. Addict Biol. 2006;11:157-162. (Pubitemid 46696808)
4. Kling MA, Carson RE, Borg L, et al. Opioid receptor Imaging with positron emission tomography and [18F]Cyclofoxy in long term, methadone-treated former heroin addicts. J Pharmacol Exp Ther. 2000;295:1070-1076.
5. Schluger JH, Bart G, Green M, et al. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects. Neuropsychopharmacology. 2003;28:985-994.
6. Sinha R, Talih M, Malison R, et al. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl). 2003;170:62-72. (Pubitemid 37372479)
7. Broadbear JH, Winger G, Cicero TJ, et al. Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. J Pharmacol Exp Ther. 1999;289:1641-1647. (Pubitemid 29246701)
8. Walter M, Wiesbeck GA, Bloch N, et al. Pychobiological responses to drug cues before and after methadone intake in heroin dependent patients: a pilot study. Eur Neuropsychopharmacol. 2008;18:390-393.
9. Walter M, Wiesbeck GA, Degen B, et al. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Addict Biol. 2011;16:145-151.
10. Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998;51:23-47. (Pubitemid 28353754)
11. Brown TT, Wisniewski AB, Dobs AS. Gonadal and adrenal abnormalities in drug users: cause or consequence of drug use behavior and poor health outcomes. Am J Infect Dis. 2006;2:130-135.
12. McKay JR, Alterman AI, Mulvaney FD, et al. Predicting proximal factors in cocaine relapse and near miss episodes: clinical and theoretical implications. Drug Alcohol Depend. 1999;56:67-78. (Pubitemid 29295380)
13. Piazza PV, Le Moal M. The role of stress in drug self-administration. Trends Pharmacol Sci. 1998;19:67-74.
14. Sinha R, Fuse T, Aubin LR, et al. Psychological stress, drug related cues and cocaine craving. Psychopharmacology. 2000;152:140-148.
15. Fox HC, Talih M, Malison R, et al. Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues. Psychoneuroendocrinology. 2005;30:880-891. (Pubitemid 40977910)
16. Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002;1:710-726. (Pubitemid 37361544)
17. Soyka M, Apelt SM, Lieb M, et al. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients. J Clin Psychopharmacol. 2006;26:657-660. (Pubitemid 44772746)
18. Oviedo-Joekes E, Brissette S, Marsh DC, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009;361:777-786.
19. Strasser J, Wiesbeck GA, Meier N, et al. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower-versus higher-dose methadone patients. J Clin Psychopharmacol. 2010;30:450-454.
20. Kreek MJ. Opiates, opioids and addiction. Mol Psychiatry. 1996;1:232-254. (Pubitemid 126441297)
21. Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann N Y Acad Sci. 2000;909:186-216. (Pubitemid 30462040)
22. Aoulzerate B, Ho A, Schluger JH, et al. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression. Addict Biol. 2006;11:84-96. (Pubitemid 46696740)
23. Stitzer ML, Sigmon SC. Other substance use disorders: prevalence, consequences, detection and management. In: Strain EC, Stitzer ML, eds. The Treatment of Opioid Dependence. Baltimore: John Hopkins University Press; 2006:365-397.
24. Dürsteler-MacFarland KM, Stohler R, Moldovanyi A, et al. Complaints of heroin-maintained patients: a survey of symptoms ascribed to diacetylmorphine. Drug Alcohol Depend. 2006;81:231-239. (Pubitemid 43152449)
25. Uchtenhagen A. Heroin-assisted treatment in Switzerland: a case study in policy change. Addiction. 2009;105:29-37.
26. Stohler R, Dü rsteler KM, Stö rmer R, et al. Rapid cortical hemoglobin deoxygenation after heroin and methadone injection in humans: a preliminary report. Drug Alcohol Depend. 1999;57:23-28. (Pubitemid 29452952)
27. Bourquin D, Bundeli P, Lehmann T, et al. Diacetylmorphine and its metabolites in plasma by HPLC with diode-array and atmospheric pressure ionization mass spectrometric detection. J Liq Chromatogr Relat Technol. 1999;22:2663-2674.
28. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). Interview and Questionnaire. Washington, DC: American Psychiatric Press; 1997.
29. Schuster CR, Greenwald MK, Johanson CE, et al. Measurement of drug craving during naloxone-precipitated withdrawal in methadone-maintained volunteers. Exp Clin Psychopharmacol. 1995;3:424-431.
30. Tiffany ST. Cognitive concepts of craving. Alcohol Res Health. 1999;23:215-224.
31. Spielberger CD. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto, Calif: Consulting Psychologists Press; 1983.
32. Kosel M, Noss RS, Hämmig R, et al. Cerebral blood flow effects of acute intravenous heroin administration. Eur Neuropsychopharmacol. 2008;18:278-285.
33. Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol. 2008;59:29-53.
34. Shaham Y, Shalev U, Lu L, et al. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology. 2003;168:3-20. (Pubitemid 36851158)
35. Shalev U, Highfiled D, Yap J, et al. Stress and relapse to drug seeking in rats: studies on generality of the effect. Psychopharmacology. 2000;150:337-346. (Pubitemid 30447854)
36. Langleben DD, Ruparel K, Elman I, et al. Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues. Am J Psychiatry. 2008;165:390-394. (Pubitemid 351704496)
37. Mei W, Zhang JX, Xiao Z. Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trail. Neuroscience. 2010;170:808-815.
38. Gerber H, Borgwardt SJ, Schmid O, et al. The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence. Eur Addict Res. 2012;18:116-123.
39. Le Moal M, Koob GF. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol. 2007;17:377-393. (Pubitemid 46497657)